Astellas Pharma, Inc. (ALPMF)

15.70 +2.05 (+15.02%) USD  |  OTCM  |  May 15, 16:00
More

Astellas Pharma EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ALPMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Takeda Pharmaceutical Co., Ltd. Upgrade
Daiichi Sankyo Co., Ltd. Upgrade
Eisai Co., Ltd. Upgrade
Chugai Pharmaceutical Co., Ltd. Upgrade